Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 26 September 2023

Tuesday, 26 September 2023

Ceisteanna (510)

Aodhán Ó Ríordáin

Ceist:

510. Deputy Aodhán Ó Ríordáin asked the Minister for Health if she will make pregabalin a controlled substance; and if he will make a statement on the matter. [40994/23]

Amharc ar fhreagra

Freagraí scríofa

Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Under the Medicinal Products (Prescription and Control of Supply) Regulations 2003 (SI 540/2003) it is a Schedule A product subject to prescription which may not be renewed. On its website HSE has advice on the appropriate prescribing of pregabalin while in September 2019 the Irish Medical Council advise all doctors prescribing pregabalin to follow best practice guidelines and to only prescribe when absolutely required. Given the prescription controls in place and the professional prescribing advice offered by both the HSE and the Irish Medical Council there are no current plans to control pregabalin under the Misuse of Drugs Act 1977.

Barr
Roinn